期刊文献+

皮肤组织晚期糖基化终产物对高血压患者血管弹性功能影响的研究 被引量:2

Effect of advanced glycation end products in skin tissue on vascular elasticity in hypertensive patients
下载PDF
导出
摘要 目的探讨高血压患者皮肤组织晚期糖基化终产物(AGE)的变化特点及与血管弹性功能异常的相关性。方法选择高血压患者157例,依据合并疾病分为高血压组62例,高血压合并糖尿病组(合并1组)42例,高血压合并糖尿病及冠心病组(合并2组)53例,同期选择健康体检者32例作为对照组。采用荷兰DiagnOptics公司AGE无创测量装置测定皮肤组织AGE水平,用皮肤自体荧光光谱(AF)值表示;采用法国Complior公司动脉弹性测定仪测定颈-股脉搏波传导速度(cf-PWV)。结果与对照组比较,高血压组、合并1组和合并2组的皮肤AF明显升高,差异有统计学意义(P<0.01);合并1组和合并2组cf-PWV明显升高(P<0.05,P<0.01)。与高血压组比较,合并1组和合并2组皮肤AF明显升高(P<0.01);合并2组cf-PWV明显升高,差异有统计学意义[(9.27±2.13)m/s vs(11.59±3.36)m/s,P<0.01]。AF与cf-PWV呈正相关(r=0.329,P=0.000)。结论高血压患者皮肤组织AGE水平增高对血管风险评价具有重要意义。 Objective To study the correlation between advanced glycation vascular elasticity in skin tissue of hypertensive hypertensive patients were divided into hyperten patients. Methods One end(AGE) prod hundred and fif ucts and ty-seven sion group(n= 62), hypertension+diabetes mellitus(DM) group(n=42) and hypertension+DM+coronary heart disease(CHD) group(n=53). Thirty-two persons who underwent health check served as a control group. AGE products in their skin tissue expressed (cf-PWV) suits The group and were detected with an invasive detector from DiagnOptics Company of Netherlands and as auto-fluorescence(AF) spectrum value. Their carotid-femoral pulse wave velocity was measured with an artery elasticity analyzer from Complior Company of France. Results The AF spectrum value was significantly higher in hypertension group, hypertension+DM hypertension+DM+CHD group than in control group(P〈0.01). The cf-PWV was significantly higher in hypertension group than in hypertension+ DM+ CHD group[ (9.27 + 2.13) m/s vs (11.59+3.36)m/s,P〈0. 01]. The AF positively correlated with the cf-PWV(r=0. 329, P=0. 000) ,indicating that the AF sion The AGE products in skin t ment of vascular risks. spectrum value is an important factor for hypertension. Concluissue of hypertensive patients play an important role in assessment of vascular risks.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2013年第3期232-235,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 中华医学会心脑血管疾病血糖管理协作组医学科研支持计划(09010044)
关键词 高血压 糖基化终产物 高级 血管疾病 葡萄糖代谢障碍 皮肤组织 hypertension glycosylation end products, advanced vascular diseases glucose metabo-lism disorders skin tissue
  • 相关文献

参考文献14

  • 1Ziem an SJ, Kass DA. Advanced glycation endproduct cross- linking in the cardiovascular system:potential therapeutic tar- get for cardiovascular disease. Drugs,2004,64:459 -470.
  • 2Semba RD, Najjar SS, Sun K, et al. Serum carboxymethyl ly- sine,an advanced glycation end product,is associated with in- creased aortic pulse wave velocity in adults. Am J Hypertens,2009,22:74- 79.
  • 3McNulty M, Mahmud A, Feely J. Advanced glycation end- products and arterial stiffness in hypertension. Am J Hyper- tens,2007,20:242-247.
  • 4中国高血压防治指南修订委员会.中国高血压防治指南.中华心血管病杂志,2010,39:579-616.
  • 52007年版中国2型糖尿病防治指南[J].中华内分泌代谢杂志,2008,24(2). 被引量:269
  • 6无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2082
  • 7Hartog JW, van de Wal RM, Schalkwijk CG, et al. Advanced glycation end-products,anti-hypertensive treatment and dias tolic function in patients with hypertension and diastolic dys- function. Eur J Heart Fail, 2010,12:397- 403.
  • 8Tanaka K, Tani Y, Asai J, et al. Skin autofluorescence is asso- ciated with severity of vascular complications in Japanese pa tients with type 2 diabetes. Diabet Med,2012,29:492- 500.
  • 9Tanaka K, Tani Y, Asai J, et al. Skin autofluorescence is asso- ciated with renal function and cardiovascular diseases in pre- dialysis chronic kidney disease patients. Nephrol Dial Trans- plant, 2011,26 : 214-220.
  • 10黄榕,邓烈华,沈安娜,许顶立.单纯收缩期高血压患者血清晚期糖基化终产物与血管功能的关系[J].中华高血压杂志,2010,18(2):148-152. 被引量:4

二级参考文献96

  • 1黄峰,林宁,陈兵,朱鹏立.老年高血压合并高胆固醇血症对大动脉结构和功能的影响[J].中国临床康复,2004,8(24):5027-5028. 被引量:4
  • 2Koyama H, Shoji T, Fukumoto S, et al. Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol, 2007,27: 147-153.
  • 3Katakami N, Ohtoshi K, Matsuhisa M, et al. Decreased endogenous secretory advanced glyeation end product receptor in type 1 diabetic patients. Diabetes Care, 2005,28:2716-2721.
  • 4Humpert PM, Morcos M, Kopf S, et al. Plasma sRAGE is independently associated with urinary albumin excretion in type 2 diabetes. Diabetes Care, 2006,29:1111-1113.
  • 5Nawroth PP, Stern DM. Soluble forms of RAGE: An index of vascular stress.? A commentary on soluble RAGE in type 2 diabetes: association with oxidative stress Free Radic Biol Med, 2007,43:506-510.
  • 6Koyama H, Shoji T, Yokoyama H, et al. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndromeand atherosclerosis. Arterioscler Thromb Vase Biol, 2005,25:2587-2593.
  • 7Geroldi D, Falcone C, Emanuele E, et al. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J Hyperteus, 2005,23:1725-1729.
  • 8Devangelio E, Santilli F, Formoso G, et al. Soluble RAGE in type 2 diabetes : association with oxidative stress. Free Radic Biol Med, 2007, 43:511-518.
  • 9Sakurai S, Yonekura H, Yamamoto T, et al. AGE-RAGE system and diabetic nephropathy. J Am Soc Nephrol, 2003,14:S259-S263.
  • 10Zieman SJ, Kass DA. Advanced glycation endproduct cross-linking in the cardiovascular system: potential therapeutic target for cardiovascular disease[J]. Drugs, 2004,64 (5) : 459-470.

共引文献2385

同被引文献14

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部